Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Johnson and Johnson
Colorcon
Novartis
Moodys
Daiichi Sankyo
Farmers Insurance
McKinsey
AstraZeneca
Harvard Business School

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,368,102

« Back to Dashboard

Summary for Patent: 7,368,102
Title:Pulmonary delivery of aminoglycosides
Abstract: The present invention is directed to the administration of aminoglycosides. In particular, the present invention is directed to compositions and methods for the pulmonary administration of aminoglycosides. According to a preferred embodiment, compositions and methods are provided for the localized treatment of respiratory infections.
Inventor(s): Tarara; Thomas E. (Burlingame, CA), Weers; Jeffry G. (Half Moon Bay, CA), Venthoye; Geraldine (Foster City, CA)
Assignee: Nektar Therapeutics (San Carlos, CA)
Application Number:10/327,510
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Delivery; Use; Device;

Drugs Protected by US Patent 7,368,102

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Novartis TOBI PODHALER tobramycin POWDER;INHALATION 201688-001 Mar 22, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y TREATMENT OF CYSTIC FIBROSIS PATIENTS WITH PSEUDOMONAS AERUGINOSA ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,368,102

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,715,623 Pulmonary delivery of aminoglycoside ➤ Sign Up
9,421,166 Pulmonary delivery of aminoglycoside ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,368,102

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Slovenia 1458360 ➤ Sign Up
Portugal 1458360 ➤ Sign Up
Mexico PA04005865 ➤ Sign Up
South Korea 100958235 ➤ Sign Up
South Korea 20040075897 ➤ Sign Up
Spain 2364636 ➤ Sign Up
Japan 2005514393 ➤ Sign Up
Japan 2011001389 ➤ Sign Up
Japan 5351120 ➤ Sign Up
European Patent Office 1458360 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cipla
Cerilliant
Cantor Fitzgerald
Chinese Patent Office
Johnson and Johnson
Julphar
McKinsey
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot